Location: Palo Alto, CA
CIK: 0001744967 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $327M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLYS | MINERALYS THERAPEUTICS INC | 4,519,361 | $42.98M | 13.2% | $16.83 | -22.5% | COM | 603170101 |
| — | RAYZEBIO INC | 1,845,948 | $40.98M | 12.5% | $22.20 | — | COM | 75525N107 |
| SRRK | SCHOLAR ROCK HLDG CORP | 4,598,828 | $32.65M | 10.0% | $7.91 | -15.1% | COM | 80706P103 |
| — | ACELYRIN INC | 2,381,579 | $24.22M | 7.4% | $20.33 | — | COM | 00445A100 |
| ACLX | ARCELLX INC | 613,921 | $22.03M | 6.7% | $16.49 | +109.1% | COMMON STOCK | 03940C100 |
| — | GRAPHITE BIO INC | 8,459,314 | $20.98M | 6.4% | $27.87 | — | COM | 38870X104 |
| — | INTERCEPT PHARMACEUTICALS IN | 640,688 | $11.88M | 3.6% | $64.16 | — | COM | 45845P108 |
| — | LYRA THERAPEUTICS INC | 2,780,261 | $10.87M | 3.3% | $5.09 | — | COM | 55234L105 |
| — | HILLEVAX INC | 799,274 | $10.75M | 3.3% | $11.56 | — | COM | 43157M102 |
| — | AVADEL PHARMACEUTICALS PLC | 967,527 | $9.966M | 3.1% | $8.30 | — | SPONSORED ADR | 05337M104 |
| ZYME | ZYMEWORKS INC | 1,458,875 | $9.249M | 2.8% | $8.72 | -15.3% | COM | 98985Y108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 345,293 | $7.916M | 2.4% | $17.86 | +25.4% | COM | 76243J105 |
| TNGX | TANGO THERAPEUTICS INC | 630,000 | $7.094M | 2.2% | $11.99 | -49.1% | COM | 87583X109 |
| — | INOZYME PHARMA INC | 1,562,500 | $6.563M | 2.0% | $4.20 | — | COM | 45790W108 |
| — | SUTRO BIOPHARMA INC | 1,675,579 | $5.814M | 1.8% | $8.61 | — | COM | 869367102 |
| — | VERONA PHARMA PLC | 347,500 | $5.664M | 1.7% | $6.18 | — | SPONSORED ADS | 925050106 |
| IOBT | IO BIOTECH INC | 3,640,015 | $5.132M | 1.6% | $3.95 | -55.5% | COM | 449778109 |
| GOSS | GOSSAMER BIO INC | 6,130,268 | $5.105M | 1.6% | $1.15 | 0.0% | COM | 38341P102 |
| ACRS | ACLARIS THERAPEUTICS INC | 696,171 | $4.769M | 1.5% | $1.36 | +527.7% | COM | 00461U105 |
| IMTX | IMMATICS N.V | 396,000 | $4.586M | 1.4% | $10.34 | +15.4% | SHS | N44445109 |
| PRME | PRIME MEDICINE INC | 470,304 | $4.487M | 1.4% | $18.06 | -28.1% | COM | 74168J101 |
| IMCR | IMMUNOCORE HLDGS PLC | 80,963 | $4.202M | 1.3% | $34.94 | — | ADS | 45258D105 |
| NKTX | NKARTA INC | 2,868,035 | $3.987M | 1.2% | $24.72 | -92.3% | COM | 65487U108 |
| JANX | JANUX THERAPEUTICS INC | 360,414 | $3.633M | 1.1% | $22.27 | -48.2% | COM | 47103J105 |
| SYRS | SYROS PHARMACEUTICALS INC | 881,450 | $3.482M | 1.1% | $4.34 | -13.8% | COM NEW | 87184Q206 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 432,000 | $3.452M | 1.1% | $11.39 | -3.7% | COM NEW | 30233G209 |
| PEPG | PEPGEN INC | 651,050 | $3.307M | 1.0% | $11.15 | -42.8% | COM | 713317105 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 196,425 | $2.41M | 0.7% | $20.76 | -37.2% | COM | 23954D109 |
| — | RAIN ONCOLOGY INC | 2,034,552 | $1.753M | 0.5% | $13.21 | — | COM | 75082Q105 |
| — | IGM BIOSCIENCES INC | 154,664 | $1.291M | 0.4% | $26.73 | — | COM | 449585108 |
| — | BOLT BIOTHERAPEUTICS INC | 1,049,153 | $1.091M | 0.3% | $23.95 | — | COM | 097702104 |
| TERN | TERNS PHARMACEUTICALS INC | 202,348 | $1.018M | 0.3% | $21.92 | -71.0% | COM | 880881107 |
| CYPH | LEAP THERAPEUTICS INC | 602,203 | $831K | 0.3% | $5.02 | -53.7% | COM NEW | 52187K200 |
| — | VTV THERAPEUTICS INC | 1,635,509 | $782K | 0.2% | $0.99 | — | CL A | 918385105 |
| — | VIRACTA THERAPEUTICS INC | 689,709 | $717K | 0.2% | $9.25 | — | COM | 92765F108 |
| — | ALLAKOS INC | 172,089 | $391K | 0.1% | $59.62 | — | COM | 01671P100 |
| — | SCIENCE 37 HOLDINGS INC | 900,000 | $360K | 0.1% | $12.47 | — | COM | 808644108 |
| — | ALLOVIR INC | 82,336 | $177K | 0.1% | $27.50 | — | COM | 019818103 |
| — | KRONOS BIO INC | 78,131 | $102K | 0.0% | $29.87 | — | COM | 50107A104 |
| — | NUVATION BIO INC | 133,333 | $13,333 | 0.0% | $0.28 | — | *W EXP 07/07/202 | 67080N119 |
| SRZNW | SURROZEN INC | 99,999 | $4,110 | 0.0% | $0.19 | — | *W EXP 08/01/203 | 86889P117 |